Total Payments
$917,853
2023 Payments
$51,278
Companies
25
Transactions
263
Payment Breakdown by Category
Consulting$848,742 (92.5%)
Travel$42,611 (4.6%)
Other$24,417 (2.7%)
Food & Beverage$1,983 (0.2%)
Education$100.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $848,742 | 169 | 92.5% |
| Travel and Lodging | $42,611 | 48 | 4.6% |
| Honoraria | $15,374 | 8 | 1.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,043 | 2 | 1.0% |
| Food and Beverage | $1,983 | 35 | 0.2% |
| Education | $100.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $340,668 | 69 | $0 (2023) |
| Horizon Pharma plc | $222,089 | 26 | $0 (2018) |
| Boehringer Ingelheim International GmbH | $68,208 | 21 | $0 (2022) |
| PFIZER INC. | $63,410 | 11 | $0 (2023) |
| Eli Lilly and Company | $45,283 | 25 | $0 (2021) |
| EMD Serono Research & Development Institute | $33,312 | 24 | $0 (2017) |
| Lilly USA, LLC | $22,504 | 20 | $0 (2019) |
| Strongbridge US INC. | $18,909 | 7 | $0 (2019) |
| Sandoz Inc. | $14,204 | 10 | $0 (2018) |
| IBSA Institut Biochimique SA | $9,778 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $51,278 | 30 | Horizon Therapeutics plc ($23,246) |
| 2022 | $92,005 | 27 | Horizon Therapeutics plc ($57,715) |
| 2021 | $100,917 | 23 | Horizon Therapeutics plc ($43,523) |
| 2020 | $86,365 | 18 | Horizon Therapeutics plc ($55,390) |
| 2019 | $236,600 | 57 | Horizon Therapeutics plc ($160,794) |
| 2018 | $236,593 | 50 | Horizon Pharma plc ($162,929) |
| 2017 | $114,094 | 58 | Horizon Pharma plc ($59,160) |
All Payment Transactions
263 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2023 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 12/01/2023 | AbbVie Inc. | RINVOQ (Biological) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/02/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Consulting Fee | Cash or cash equivalent | $1,595.00 | General |
| Category: KRYSTEXXA | ||||||
| 10/20/2023 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $348.19 | General |
| 10/20/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $134.67 | General |
| 10/20/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $60.00 | General |
| 10/20/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $51.63 | General |
| 10/20/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $30.00 | General |
| 10/20/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $30.00 | General |
| 09/15/2023 | Teikoku Pharma USA, Inc. | Dexmedetomidine (Drug) | Consulting Fee | Cash or cash equivalent | $4,927.50 | General |
| Category: Postoperative Analgesia | ||||||
| 09/15/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Consulting Fee | Cash or cash equivalent | $1,885.00 | General |
| Category: TEPEZZA | ||||||
| 09/13/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Consulting Fee | Cash or cash equivalent | $1,786.40 | General |
| Category: TEPEZZA | ||||||
| 09/08/2023 | AbbVie Inc. | RINVOQ (Biological) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Consulting Fee | Cash or cash equivalent | $3,190.00 | General |
| Category: TEPEZZA | ||||||
| 08/07/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,375.00 | General |
| 06/20/2023 | AbbVie Inc. | RINVOQ (Biological) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: IMMUNOLOGY | ||||||
| 06/13/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Consulting Fee | Cash or cash equivalent | $1,305.00 | General |
| Category: KRYSTEXXA | ||||||
| 05/09/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Consulting Fee | Cash or cash equivalent | $1,885.00 | General |
| Category: TEPEZZA | ||||||
| 05/04/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Consulting Fee | Cash or cash equivalent | $4,625.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/01/2023 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Honoraria | Cash or cash equivalent | $750.00 | General |
| Category: Pain Management | ||||||
| 04/26/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Consulting Fee | Cash or cash equivalent | $5,365.00 | General |
| Category: KRYSTEXXA | ||||||
| 03/27/2023 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $275.00 | General |
| 03/16/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Consulting Fee | Cash or cash equivalent | $1,160.00 | General |
| Category: KRYSTEXXA | ||||||
| 03/03/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
About Dr. Lee Simon, M.D
Dr. Lee Simon, M.D is a Rheumatology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1457494932.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lee Simon, M.D has received a total of $917,853 in payments from pharmaceutical and medical device companies, with $51,278 received in 2023. These payments were reported across 263 transactions from 25 companies. The most common payment nature is "Consulting Fee" ($848,742).
Ad
Practice Information
- Specialty Rheumatology
- Location Boston, MA
- Active Since 02/15/2007
- Last Updated 07/08/2007
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1457494932
Products in Payments
- QUINSAIR (Drug) $175,197
- KRYSTEXXA (Biological) $119,075
- TEPEZZA (Drug) $30,763
- Atacicept (Biological) $18,900
- NONE (Drug) $12,035
- KRYSTEXXA (Drug) $11,307
- RAYOS (Drug) $10,730
- Exparel (Drug) $9,751
- DUEXIS (Drug) $7,395
- ACZ885D (Biological) $6,828
- LUPKYNIS (Drug) $6,771
- Dexmedetomidine (Drug) $4,928
- RINVOQ (Biological) $4,500
- AIHA $3,750
- Sprifermin (Biological) $3,600
- AIHA (Drug) $3,548
- NO_PRODUCT (Drug) $2,960
- PROCYSBI (Drug) $2,465
- Zilretta (Drug) $1,688
- IONSYS (Drug) $1,015
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Boston
Michael Weinblatt, Md, MD
Rheumatology — Payments: $408,548
Rheumatology $408,548
Sebastian Unizony, Md, MD
Rheumatology — Payments: $172,168
Rheumatology $172,168
Jack Bukowski, Md Phd, MD PHD
Rheumatology — Payments: $153,965
Rheumatology $153,965
Michael Brenner, Md, MD
Rheumatology — Payments: $141,423
Rheumatology $141,423
Dr. Joerg Ermann, Md, MD
Rheumatology — Payments: $131,409
Rheumatology $131,409
Robert Lafyatis
Rheumatology — Payments: $119,295
Rheumatology $119,295